BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26437012)

  • 41. Glyburide: the new alternative for treating gestational diabetes?
    Durnwald C; Landon MB
    Am J Obstet Gynecol; 2005 Jul; 193(1):1-2. PubMed ID: 16021049
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of glyburide and insulin in women with gestational diabetes mellitus.
    Langer O; Conway DL; Berkus MD; Xenakis EM; Gonzales O
    N Engl J Med; 2000 Oct; 343(16):1134-8. PubMed ID: 11036118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gestational diabetes mellitus: what is the optimal treatment modality?
    Cheng YW; Caughey AB
    J Perinatol; 2007 May; 27(5):257-8. PubMed ID: 17453037
    [No Abstract]   [Full Text] [Related]  

  • 44. Neonatal chemical hypoglycemia in newborns from pregnancies complicated by type 2 and gestational diabetes mellitus - the importance of neonatal ponderal index.
    Ramos GA; Hanley AA; Aguayo J; Warshak CR; Kim JH; Moore TR
    J Matern Fetal Neonatal Med; 2012 Mar; 25(3):267-71. PubMed ID: 21557689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk.
    Bouchghoul H; Alvarez JC; Verstuyft C; Bouyer J; Senat MV
    PLoS One; 2020; 15(5):e0232002. PubMed ID: 32379777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety considerations with pharmacological treatment of gestational diabetes mellitus.
    Simmons D
    Drug Saf; 2015 Jan; 38(1):65-78. PubMed ID: 25542297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glyburide for the treatment of gestational diabetes. A critical appraisal.
    Moore TR
    Diabetes Care; 2007 Jul; 30 Suppl 2():S209-13. PubMed ID: 17596474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological treatment of gestational diabetes mellitus: point/counterpoint.
    Langer O
    Am J Obstet Gynecol; 2018 May; 218(5):490-499. PubMed ID: 29499921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comment on 'Glyburide as treatment option for gestational diabetes mellitus'.
    Gupta Y
    J Obstet Gynaecol Res; 2014 Feb; 40(2):638. PubMed ID: 24620370
    [No Abstract]   [Full Text] [Related]  

  • 50. Breakthrough in treating gestational diabetes mellitus.
    Koren G
    Can Fam Physician; 2004 Jul; 50():987, 989. PubMed ID: 15317230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glyburide: caution for efficacy and fetal programming effects.
    Ross MG; Kjos SL
    Am J Obstet Gynecol; 2010 Apr; 202(4):e8; author reply e8-9. PubMed ID: 20031111
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral agents for the management of gestational diabetes.
    Berggren EK; Boggess KA
    Clin Obstet Gynecol; 2013 Dec; 56(4):827-36. PubMed ID: 24005130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoglycemia in glyburide-treated gestational diabetes: is it dose-dependent?
    Spellacy WN
    Obstet Gynecol; 2011 Aug; 118(2 Pt 1):358. PubMed ID: 21775857
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis.
    Dhulkotia JS; Ola B; Fraser R; Farrell T
    Am J Obstet Gynecol; 2010 Nov; 203(5):457.e1-9. PubMed ID: 20739011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    Jacobson GF; Ramos GA; Ching JY; Kirby RS; Ferrara A; Field DR
    Am J Obstet Gynecol; 2005 Jul; 193(1):118-24. PubMed ID: 16021069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glyburide in gestational diabetes--prediction of treatment failure.
    Yogev Y; Melamed N; Chen R; Nassie D; Pardo J; Hod M
    J Matern Fetal Neonatal Med; 2011 Jun; 24(6):842-6. PubMed ID: 21067291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin.
    Joy S; Roman A; Istwan N; Rhea D; Desch C; Stanziano G; Saltzman D
    Am J Perinatol; 2012 Sep; 29(8):643-8. PubMed ID: 22644829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral hypoglycaemic agents during pregnancy: The evidence for effectiveness and safety.
    Nicholson W; Baptiste-Roberts K
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):51-63. PubMed ID: 21251886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-insulin pharmacological therapy in pregnancy.
    Bajaj S
    J Pak Med Assoc; 2016 Sep; 66(9 Suppl 1):S45-7. PubMed ID: 27582151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of glyburide failure in the treatment of gestational diabetes.
    Kahn BF; Davies JK; Lynch AM; Reynolds RM; Barbour LA
    Obstet Gynecol; 2006 Jun; 107(6):1303-9. PubMed ID: 16738156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.